/
PROGEN.ST
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Prostatype Genomics AB (publ)
Prostatype Genomics AB focuses on creating, marketing, and selling sophisticated prognostic gene tests. Their primary offering, the Prostatype Test System, combines genetic expression data with key clinical measurements such as PSA levels, Gleason Score, and Tumor Stage to determine a specific P-score. This advanced diagnostic tool is built upon a vast database of prostate cancer patients, providing crucial support for patients and medical practitioners when deciding on treatment strategies. Founded in 2007, the company is headquartered in Solna, Sweden.
www.prostatypegenomics.com- Employees
- 7
- IPO / List date
- Nov 3, 2020
- HQ
- SE
Held by traders on TradeandTell
No one on the platform currently holds PROGEN.ST.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PROGEN.ST as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded PROGEN.ST yet.